Skip to content

A multicenter, randomized, controlled trial for the analysis of minimally invasive surgical strategies for different types of kidney stones

A multicenter, randomized, controlled trial for the analysis of minimally invasive surgical strategies for different types of kidney stones

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019553
Enrollment
Unknown
Registered
2018-11-18
Start date
2018-06-01
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney stone

Interventions

Group 1:16F PCNL
Group 2:20F PCNL
Group 3:Microperc
Group 4:Retrograde intrarenal surgery
Group 5:Multi-tract PCNL
Group 6:Combined micro-and standard percutaneous nephrolithotomy

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years old male and female; 2. The patient has no mental illness or language impairment, understands the condition of this study and has signed an informed consent; 3. No clinical manifestations of urinary infection, urinary tract infection was indicated by routine examination of urine, but negative urine pathogenic examination (increased urinary routine leukocyte) was found after 3 days of broad-spectrum antibiotic treatment; 4. Clinical manifestations of urinary tract infection, routine examination of urine suggests urinary tract infection, positive results of uropathogeny examination, treated by sensitive antibiotics for more than 7 days

Exclusion criteria

Exclusion criteria: 1. Transplant kidney; 2. Diseases of the blood system and abnormal coagulation function; 3. Taking anticoagulants such as aspirin, warfarin, dabigatran, rivaroxaban, and alperoxaban for more than 2 weeks; 4. Fever or urinary tract infection is not treated according to the inclusion criteria; 5. Pregnant women and women menstruate; 6. Complications such as severe systemic disease, heart disease, pulmonary insufficiency, and major organ failure cannot tolerate anesthesia or surgery.

Design outcomes

Primary

MeasureTime frame
Stone free rate;

Secondary

MeasureTime frame
Operation time;Complications;Renal function;hemoglobin;Pain score;

Countries

China

Contacts

Public ContactCheng Fan

Renmin Hospital of Wuhan University

urology1969@aliyun.com+86 13307105017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026